Transdermal Delivery of Icariin via Microneedle Patches Attenuates Phthalate‐Induced Testicular Injury
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Chunyan Fang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Quality Standard and Testing Technology For Agro-Products, Sichuan Academy of Agricultural Sciences, Chengdu, China. Hauptthemen laut MEDLINE: Testis, Flavonoids, Diethylhexyl Phthalate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Original Innovation 2035 Project of Sichuan Academy of Agricultural Sciences, Independent Innovation Project of Sichuan Academy of Agricultural Sciences.
Abstract (Originalsprache)
Di‐(2‐ethylhexyl) phthalate (DEHP) is a prevalent plasticizer that has been demonstrated to induce male reproductive toxicity through the disruption of spermatogenesis. Icariin (ICA), a bioactive compound derived from the traditional Chinese medicine Epimedium, holds significant potential in the treatment of male infertility. However, its clinical utilization is constrained by low absorption and fast metabolism upon oral administration. Herein, we first developed ICA‐loaded chondroitin sulfate (CS) and polyvinylpyrrolidone K30 (PVP K30) microneedle (MN) patches (ICA MNs) for treating DEHP‐induced testicular dysfunction. The results found that ICA MNs significantly reduced DEHP‐induced oxidative stress and apoptosis in GC‐1 cells by modulating the Keap1/Nrf2/HO‐1 pathway. In addition, ICA MNs mitigated DEHP‐induced testicular damage, sperm irregularities, and blood‐testis barrier impairment in rats, surpassing the efficacy of oral ICA treatment. Proteomic analysis indicated a restoration of the testicular proteome toward normal levels after ICA MN treatment. Comprehensive safety assessments revealed no adverse systemic effects, highlighting the biocompatibility of ICA MNs. These findings suggest ICA MNs as a promising therapeutic approach for male infertility associated with DEHP exposure, offering targeted and efficient transdermal delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Quality Standard and Testing Technology For Agro-Products, Sichuan Academy of Agricultural Sciences, Chengdu, China.
- Tea Research Institute, Sichuan Academy of Agricultural Sciences, Chengdu, China.
- Department of Laboratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Department of Food Science and Nutrition, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China.
- Research Institute for Future Food, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China.
- Chengdu Sport University, Chengdu, China.
ORCID-Profile: Yulong Ye
Förderung
- Original Innovation 2035 Project of Sichuan Academy of Agricultural Sciences
- Independent Innovation Project of Sichuan Academy of Agricultural Sciences
Zitieren
APA
Fang, C., Li, Y., You, R., Wong, K. H., Cai, T., Gan, R. Y., & Ye, Y. (2026). Transdermal Delivery of Icariin via Microneedle Patches Attenuates Phthalate‐Induced Testicular Injury. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503925
Vancouver
Fang C, Li Y, You R, Wong KH, Cai T, Gan RY, et al. Transdermal Delivery of Icariin via Microneedle Patches Attenuates Phthalate‐Induced Testicular Injury. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503925
BibTeX
@article{Fang2026,
author = {Fang, Chunyan and Li, Yuchen and You, Rui and Wong, Ka-Hing and Cai, Tao and Gan, Ren-You and Ye, Yulong},
title = {Transdermal Delivery of Icariin via Microneedle Patches Attenuates Phthalate‐Induced Testicular Injury},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503925}
}
EUVIMED